웨이브 라이프사이언스(주)
DE ˙ DB ˙ SG9999014716
€4.60 ↓ -0.20 (-4.17%)
2026-06-04
주가
SecurityDE:1U5 / Wave Life Sciences Ltd.
InstitutionMan Group plc
Latest Disclosed Ownership64,036 shares
Latest Disclosed Value $ 464,261
Man Group plc reports 103.82% increase in ownership of 1U5 / Wave Life Sciences Ltd.

On May 15, 2026 - Man Group plc filed a 13F-HR form disclosing ownership of 64,036 shares of Wave Life Sciences Ltd. (DE:1U5) valued at $352,198 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 31,418 shares of Wave Life Sciences Ltd.. This represents a change in shares of 103.82% during the quarter. The current value of the position is $294,566 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 64,036 32,618 103.82 464 -13.11 0.0005
2026-02-17 2025-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 31,418 -101,353 -76.34 534 -45.01 0.0009
2025-11-14 2025-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 132,771 73,492 123.98 972 152.21 0.0017
2025-08-14 2025-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 59,279 385 169.23 0.0007
2023-05-15 2023-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 143 15.32 0.0005
2023-02-14 2022-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 17,842 17,842 125 0.0004
2021-08-16 2021-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 0 -11,415 -100.00 0 -100.00
2021-05-17 2021-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 11,415 -75,700 -86.90 64 -90.67 0.0003
2021-02-16 2020-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 87,115 87,115 686 0.0030
2019-02-14 2018-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 0 -5,748 -100.00 0 -100.00
2018-11-14 2018-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 5,748 5,748 287 0.0010
2018-08-14 2018-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 0 -5,458 -100.00 0 -100.00
2018-05-15 2018-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 5,458 5,458 219 0.0010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.